MDRX logo

Veradigm (MDRX) Shareholders Equity

Annual Shareholders Equity

$1.41 B
-$258.11 M-15.49%

December 31, 2021

Summary

Performance

1-Year Change

-15.49%

3-Year Change

-9.22%

5-Year Change

+25.63%

15-Year Change

+25.63%

MDRX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.79%
MDRX annual stockholders equity is higher than 90.79% of companies in Healthcare sector

High & Low

All-time High

$1.67 B
MDRX annual stockholders equity is currently -15.49% below its historical high of $1.67 billion

3-Year Low

$1.41 B
MDRX annual stockholders equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
MDRX previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
MDRX next annual earnings announcement has not yet been scheduled

OtherMDRXbalance sheetmetrics:

Annual Retained Earnings

$767.56 M
MDRX annual retained earnings is $767.56 million

Annual Working Capital

$214.26 M
MDRX annual working capital is $214.26 million

Annual Total Assets

$2.43 B
MDRX annual total assets is $2.43 billion

Annual Total Liabilities

$1.02 B
MDRX annual total liabilities is $1.02 billion

Quarterly Shareholders Equity

$1.18 B
-$19.32 M-1.62%

September 30, 2022

Summary

Performance

3-Month Change

-1.62%

1-Year Change

-17.03%

3-Year Change

-5.21%

5-Year Change

-5.21%

MDRX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.32%
MDRX quarterly stockholders equity is higher than 89.32% of companies in Healthcare sector

High & Low

All-time High

$1.68 B
MDRX quarterly stockholders equity is currently -29.88% below its historical high of $1.68 billion

3-Year Low

$1.18 B
MDRX quarterly stockholders equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
MDRX previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
MDRX next earnings announcement has not yet been scheduled

OtherMDRXbalance sheetmetrics:

Quarterly Retained Earnings

$753.39 M
MDRX quarterly retained earnings is $753.39 million

Quarterly Working Capital

$557.68 M
MDRX quarterly working capital is $557.68 million

Quarterly Total Assets

$1.69 B
MDRX quarterly total assets is $1.69 billion

Quarterly Total Liabilities

$513.64 M
MDRX quarterly total liabilities is $513.64 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$1.41 B
MDRX annual stockholders equity is $1.41 billion

Annual Total Assets

$2.43 B
MDRX annual total assets is $2.43 billion

Annual Total Liabilities

$1.02 B
MDRX annual total liabilities is $1.02 billion

MDRX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.5%-17.0%
3 y3 years-9.2%-5.2%
5 y5 years+25.6%-5.2%

MDRX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-16.4%at low
5 y5-year-15.5%+9.6%-29.9%at low
alltimeall time-15.5%>+9999.0%-29.9%>+9999.0%

Veradigm Shareholders Equity History

DateAnnualQuarterly
Sep 2022
-
$1.18 B(-1.6%)
Jun 2022
-
$1.20 B(-11.6%)
Mar 2022
-
$1.35 B(-3.9%)
Dec 2021
$1.41 B(-15.5%)
$1.41 B(-0.7%)
Sep 2021
-
$1.42 B(+1.8%)
Jun 2021
-
$1.39 B(-17.0%)
Mar 2021
-
$1.68 B(+0.7%)
Dec 2020
$1.67 B(+29.6%)
$1.67 B(+37.9%)
Sep 2020
-
$1.21 B(-2.8%)
Jun 2020
-
$1.24 B(+0.1%)
Mar 2020
-
$1.24 B(-3.4%)
Dec 2019
$1.29 B(-17.1%)
$1.29 B(+0.3%)
Sep 2019
-
$1.28 B(-2.7%)
Jun 2019
-
$1.32 B(-9.6%)
Mar 2019
-
$1.46 B(-6.1%)
Dec 2018
$1.55 B(+38.4%)
$1.55 B(+42.6%)
Sep 2018
-
$1.09 B(-2.2%)
Jun 2018
-
$1.11 B(+3.8%)
Mar 2018
-
$1.07 B(-4.4%)
Dec 2017
$1.12 B(-9.1%)
$1.12 B(+1.4%)
Sep 2017
-
$1.11 B(-1.7%)
Jun 2017
-
$1.12 B(-2.0%)
Mar 2017
-
$1.15 B(-6.9%)
Dec 2016
$1.23 B(-12.5%)
$1.23 B(-7.3%)
Sep 2016
-
$1.33 B(-0.8%)
Jun 2016
-
$1.34 B(-2.8%)
Mar 2016
-
$1.38 B(-2.1%)
Dec 2015
$1.41 B(+9.6%)
$1.41 B(+1.7%)
Sep 2015
-
$1.38 B(+0.1%)
Jun 2015
-
$1.38 B(+8.2%)
Mar 2015
-
$1.28 B(-0.5%)
Dec 2014
$1.28 B(-2.6%)
$1.28 B(+0.1%)
Sep 2014
-
$1.28 B(-1.3%)
Jun 2014
-
$1.30 B(-0.6%)
Mar 2014
-
$1.31 B(-0.8%)
Dec 2013
$1.32 B(+2.6%)
$1.32 B(-1.0%)
Sep 2013
-
$1.33 B(-2.7%)
Jun 2013
-
$1.37 B(+2.5%)
Mar 2013
-
$1.33 B(+3.9%)
Dec 2012
$1.28 B(-13.0%)
$1.28 B(-1.1%)
Sep 2012
-
$1.30 B(+1.4%)
Jun 2012
-
$1.28 B(-14.0%)
Mar 2012
-
$1.49 B(+0.9%)
Dec 2011
$1.48 B(+6.7%)
$1.48 B(+2.6%)
Sep 2011
-
$1.44 B(+2.2%)
Jun 2011
-
$1.41 B(-1.4%)
Mar 2011
-
$1.43 B(+4.3%)
Dec 2010
$1.38 B
-
DateAnnualQuarterly
Sep 2010
-
$1.37 B(+69.6%)
May 2010
-
$806.83 M(+2.5%)
May 2010
$806.83 M(+15.2%)
-
Feb 2010
-
$787.23 M(+2.8%)
Nov 2009
-
$765.74 M(+3.8%)
Aug 2009
-
$737.57 M(+5.3%)
May 2009
$700.37 M(+105.6%)
$700.37 M(-2.7%)
Feb 2009
-
$719.44 M(+2.1%)
Nov 2008
-
$704.93 M(+99.6%)
Sep 2008
-
$353.26 M(+1.7%)
Jun 2008
-
$347.45 M(+1.5%)
Mar 2008
-
$342.45 M(+0.5%)
Dec 2007
$340.64 M(+7.7%)
$340.64 M(+2.5%)
Sep 2007
-
$332.29 M(-1.1%)
Jun 2007
-
$336.00 M(+3.7%)
Mar 2007
-
$323.88 M(+2.4%)
Dec 2006
$316.25 M(+221.3%)
$316.25 M(+3.3%)
Sep 2006
-
$306.18 M(+3.2%)
Jun 2006
-
$296.70 M(+1.8%)
Mar 2006
-
$291.57 M(+196.3%)
Dec 2005
$98.42 M(+25.1%)
$98.42 M(+4.9%)
Sep 2005
-
$93.86 M(+7.2%)
Jun 2005
-
$87.53 M(+5.1%)
Mar 2005
-
$83.30 M(+5.9%)
Dec 2004
$78.69 M(-5.6%)
$78.69 M(+3.4%)
Sep 2004
-
$76.12 M(-11.6%)
Jun 2004
-
$86.12 M(+1.6%)
Mar 2004
-
$84.75 M(+1.6%)
Dec 2003
$83.39 M(-2.8%)
$83.39 M(+0.4%)
Sep 2003
-
$83.06 M(+1.7%)
Jun 2003
-
$81.64 M(-2.5%)
Mar 2003
-
$83.73 M(-2.4%)
Dec 2002
$85.82 M(-13.0%)
$85.82 M(-2.3%)
Sep 2002
-
$87.85 M(-3.2%)
Jun 2002
-
$90.77 M(-4.0%)
Mar 2002
-
$94.53 M(-4.2%)
Dec 2001
$98.63 M(-66.1%)
$98.63 M(-8.1%)
Sep 2001
-
$107.27 M(-76.6%)
Jun 2001
-
$458.74 M(-5.7%)
Mar 2001
-
$486.34 M(+67.1%)
Dec 2000
$290.98 M(+331.7%)
$290.98 M(-4.9%)
Sep 2000
-
$305.84 M(-4.8%)
Jun 2000
-
$321.31 M(+81.9%)
Mar 2000
-
$176.65 M(+162.1%)
Dec 1999
$67.40 M(+1082.5%)
$67.40 M(-6.3%)
Sep 1999
-
$71.90 M(+1309.8%)
Jun 1999
-
$5.10 M(-29.2%)
Mar 1999
-
$7.20 M
Dec 1998
$5.70 M
-

FAQ

  • What is Veradigm annual stockholders equity?
  • What is the all time high annual shareholders equity for Veradigm?
  • What is Veradigm annual shareholders equity year-on-year change?
  • What is Veradigm quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Veradigm?
  • What is Veradigm quarterly shareholders equity year-on-year change?

What is Veradigm annual stockholders equity?

The current annual shareholders equity of MDRX is $1.41 B

What is the all time high annual shareholders equity for Veradigm?

Veradigm all-time high annual stockholders equity is $1.67 B

What is Veradigm annual shareholders equity year-on-year change?

Over the past year, MDRX annual stockholders equity has changed by -$258.11 M (-15.49%)

What is Veradigm quarterly stockholders equity?

The current quarterly shareholders equity of MDRX is $1.18 B

What is the all time high quarterly shareholders equity for Veradigm?

Veradigm all-time high quarterly stockholders equity is $1.68 B

What is Veradigm quarterly shareholders equity year-on-year change?

Over the past year, MDRX quarterly stockholders equity has changed by -$241.56 M (-17.03%)